US20030017573A1
University of Texas System
The present invention concerns compositions and methods involving mammalian polymerase kappa, an enzyme with limited fidelity and moderate processivity. Methods of modulating polymerase kappa activity, such as inhibiting or reducing its activity, as a means of effecting a cancer treatment or …